跳至主要内容
临床试验/NCT07269015
NCT07269015尚未招募不适用

Evaluation of the Accuracy of Continuous Glucose Monitoring Systems and Educational Needs in Pregnant Women With Diabetes: A Comparison Between Dexcom One Plus and FreeStyle Libre 2 Plus

Hospital Mutua de Terrassa2 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
66
试验地点
2
主要终点
Baseline diabetes knowledge, skills, and attitudes

研究概览

简要总结

Pregnancy in women with diabetes remains a high-risk condition, requiring strict glycemic control due to rapid physiological changes that affect insulin sensitivity. Continuous glucose monitoring (CGM) provides detailed glucose trends, but the accuracy of newer, affordable systems such as Dexcom One Plus and FreeStyle Libre 2 Plus has not been evaluated during pregnancy.

This prospective interventional study aims to compare the accuracy of these two CGM systems-both worn simultaneously-using capillary glucose as the reference. The study also evaluates educational needs, skills, attitudes, digital competence, lifestyle habits, and patient-reported outcomes among pregnant women with type 1 diabetes (T1D), type 2 diabetes (T2D), and gestational diabetes (GDM).

详细描述

Women with diabetes during pregnancy experience increased risks of congenital malformations, neonatal morbidity, hypertensive disorders, and abnormal fetal growth. Continuous glucose monitoring (CGM) improves glycemic outcomes in type 1 diabetes (T1D) in pregnancy, yet evidence remains limited for type 2 diabetes (T2D) and gestational diabetes (GDM). Dexcom One Plus and FreeStyle Libre 2 Plus are recent low-cost systems with CE-mark approval for use in pregnancy, both with reported Mean Absolute Relative Difference (MARD) values around 8%. However, neither system has been specifically validated in pregnant populations.

Physiological changes in pregnancy-including increased total body water and interstitial fluid-may alter CGM accuracy. Prior studies show that earlier FreeStyle Libre versions may overestimate hypoglycemia in pregnant women. Furthermore, women with T2D or GDM typically have little prior exposure to diabetes education or CGM technology, which may contribute to suboptimal glycemic control.

This study evaluates the accuracy and usability of Dexcom One Plus and FreeStyle Libre 2 Plus during pregnancy, while also assessing educational and digital literacy needs to optimize CGM implementation in real-world clinical practice.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women with type 1 diabetes, type 2 diabetes, or gestational diabetes, diagnosed before 32 weeks of gestation
  • Age ≥18 years
  • Willingness to wear two CGM systems simultaneously
  • Possession of a smartphone compatible with LibreLink
  • Ability to sign informed consent

排除标准

  • Comorbidities affecting glucose metabolism
  • Inability to use CGM devices or perform capillary glucose testing

结局指标

主要结局

Baseline diabetes knowledge, skills, and attitudes

时间窗: Baseline (first study visit)

For the baseline evaluation, a specific questionnaire for the present study was administered, and the Spanish version of the Cambados Questionnaire will also be used. The Cambados Questionnaire is a 5-item questionnaire designed to assess digital competence. The score range is from 0 to 20. Higher scores indicate greater digital competence.

Mean Absolute Relative Difference (MARD)

时间窗: End of 30-day monitoring period; Primary outcome

Difference between paired continuous glucose monitoring (CGM) readings (Dexcom One Plus vs. FreeStyle Libre 2 Plus) and reference capillary glucose values.

次要结局

  • Dietary habits (Mediterranean diet adherence)(Baseline and End of 30-day monitoring period)
  • Sleep quality(Baseline and through study completion, an average of 1 week)
  • Patient-reported outcomes (PROMs)(Through study completion, an average of 1 week)
  • Mean Absolute Difference (MAD) for glucose <70 mg/dL(End of 30-day monitoring period)
  • Agreement rates (15/15%, 20/20%, 40/40%) across glucose ranges(End of 30-day monitoring period)
  • Physical activity(7 days before baseline and through study completion, an average of 1 week)

研究者

发起方
Hospital Mutua de Terrassa
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验